Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging 24-Week Study to Evaluate the Safety and Efficacy of a Single Injection of CNTX-4975 in Subjects With Chronic, Moderate to Severe Osteoarthritis Knee Pain

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 02 May 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

29 Apr 2019 According to a Centrexion Therapeutics media release, results from this study will be presented at the 2019 British Society for Rheumatology (BSR) Annual Conference.
27 Mar 2019 According to a Centrexion Therapeutics media release, final article (for results published online in the journal Arthritis & Rheumatology) will be available in the forthcoming print issue of Arthritis & Rheumatology.
27 Mar 2019 Results presented in a Centrexion Therapeutics media release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com